Greenwich LifeSciences, Inc. (GLSI) vs MacroGenics, Inc. (MGNX)
A side-by-side comparison of Greenwich LifeSciences, Inc. and MacroGenics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GLSI
Greenwich LifeSciences, Inc.
$16.44HealthcareDelayed quote: Oct 6, 2026, 1:28 PM EDT
MGNX
MacroGenics, Inc.
$3.64HealthcareDelayed quote: Oct 6, 2026, 1:30 PM EDT
Total return — GLSI vs MGNX
growth of $100 · dividends reinvested · last 6yGLSI +238.2% (+22.5%/yr)MGNX -84.9% (-27.1%/yr)GLSI compounded faster over this window
Log scale — wide-divergence pair
GLSI MGNX
GLSI vs MGNX: by the numbers
- •GLSI is the larger company ($241M vs $231M market cap).
- •Both run net losses; GLSI's is the smaller (0.00% vs -8.70% net margin).
Metrics side by side
Valuation
| Metric | GLSI | MGNX |
|---|---|---|
| P/S ratio | N/A | 1.38 |
| P/B ratio | 77.42 | 5.39 |
Profitability
| Metric | GLSI | MGNX |
|---|---|---|
| Gross margin | 0.00% | 71.12% |
| Operating margin | 0.00% | -48.72% |
| Net margin | 0.00% | -8.70% |
| ROE | -695.56% | -34.04% |
| ROIC | -701.55% | -16.87% |
Growth (annualized)
| Metric | GLSI | MGNX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 7.33% |
| Total return CAGR (5Y) | -14.84% | -28.42% |
Frequently asked
- How have GLSI and MGNX total returns compared?
- Over the past 5 years, GLSI delivered -14.84% and MGNX delivered -28.42% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.